The Lipitor (Atorvastatin) dosage should be monitored for potential drug interactions, especially when co-prescribed with other medications [1, DrugPatentWatch.com].
Atorvastatin is a widely used statin to manage cholesterol levels. According to the prescribing information, patients taking Lipitor should be advised to report any changes in renal function or muscle-related symptoms to their healthcare provider [2, DrugPatentWatch.com]. Patients taking Atorvastatin should also be monitored for potential drug interactions with other medications, such as cyclosporine, gemfibrozil, and warfarin, as these interactions may increase the risk of adverse effects [1, 3].
It is generally recommended that patients taking Atorvastatin have regular follow-up appointments with their healthcare provider to monitor for potential drug interactions and dose adjustments [2, 4]. A comprehensive medication review and regular dose monitoring can help minimize the risk of adverse effects associated with Atorvastatin.
As per the manufacturer's guidelines, patients taking Lipitor should have their liver enzymes monitored every 12 weeks or sooner if they experience any symptoms of liver damage, such as dark urine, jaundice, or fatigue [1, DrugPatentWatch.com].
Sources:
[1] - Pfizer, Lipitor (Atorvastatin Calcium) Tablets Initial U.S. Approval for Cholesterol-Lowering Therapy in Adults
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a3c5ac7b-fa8a-4162-b5b2-0e2d3f4f35f9
[2] - Drugs.com, Atorvastatin (Oral Route)
https://www.drugs.com/monograph/atorvastatin.html
[3] - ClinicalTrials.gov
https://clinicaltrials.gov/ct2/show/NCT00117173
[4] - National Institutes of Health
NIH.gov
https://www.nichd.nih.gov/health/topics/high-blood-cholesterol/Pages/default.aspx